Global Pharma Briefs: News from Pfizer, AstraZeneca, BMS, and Takeda
By

By
A roundup of news from Africa (BioNTech), Canada (Genevant, Takeda), Germany (BMS, Evotec) India (Cipla, Kemwell) and the US (Pfizer, AstraZeneca, Thermo Fisher and others). Africa BioNTech To Establish mRNA…

Pharma COVID Roundup: News from Pfizer, Moderna, Merck & Co., GSK
By

By
The latest on COVID-19 vaccines/drugs from Pfizer, Moderna, Merck & Co., Lilly, GlaxoSmithKline, SK bioscience, CureVac, and Novavax.  Updates on COVID-19 treatments and vaccines FDA To Hold Meeting on Pfizer’s/BioNTech’s…

Roche, Shape Therapeutics Form $3-Bn Gene-Therapy Pact
By

By
Roche and Shape Therapeutics, a Seattle, Washington-based company developing RNA technologies for gene therapies, have entered into a multi-target collaboration and license agreement, worth up to $3 billion, to advance…

Lilly, Lycia in $1.6-Bn Pact Based on Protein-Degradation Technology
By

By
Eli Lilly and Company and Lycia Therapeutics, a South San Francisco, California-based bio/pharmaceutical company, have entered into a multi-year research collaboration and licensing agreement for the discovery, development, and commercialization…

Pharma COVID Roundup: News from Roche, Moderna, Merck & Co., and GSK
By

By
The latest on COVID-19 vaccines/drugs, manufacturing, and testing from Roche, Moderna, Merck & Co., GSK, CureVac, Gristone, CEPI, and Thermo Fisher Scientific. Manufacturing and supply of COVID-19 vaccines and drugs…

Global Pharma Briefs: News from BI, CureVac, Atriva & Alladapt
By

By
A roundup of news from Germany (Boehringer Ingelheim and CureVac) and the US (Artiva Biotherapeutics and Alladapt Immunotherapeutics). Germany BI, CureVac To End mRNA Cancer Vaccine PactCureVac, a Tubingen, Germany-based…

Pharma COVID Roundup: News from AstraZeneca, Moderna, Thermo Fisher
By

By
The latest on COVID-19 vaccines/drugs, manufacturing, and testing from AstraZeneca, Moderna, Sk Bioscience, Inovio, Sinovac, the FDA, the World Health Organization, and Thermo Fisher Scientific. Manufacturing and supply of COVID-19…

Moderna, Canadian Gov’t Plan Pact for New mRNA Mfg Facility
By

By
Moderna, a bio/pharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, has announced a memorandum of understanding with the Canadian government to build a mRNA vaccine-manufacturing facility in Canada. The…

Global Pharma Briefs; News from Astellas, Gilead, and Alnylam
By

By
A roundup of news from Japan (Astellas, Minovia) and the US (Gilead Sciences, Alnylam, Lumen Bioscience, and Spectrum Pharmaceuticals). Japan Astellas, Minovia Therapeutics in Cell-Therapy PactAstellas and Minovia Therapeutics, a…

Gilead, Appia Bio in $875-M Pact for Allogeneic Cell Therapies
By

By
Kite, part of Gilead Sciences, and Appia Bio, a Los Angeles, California-based bio/pharmaceutical company developing engineered allogeneic cell therapies from hematopoietic stem cells (HSCs), have entered into a collaboration and…